0.6288 USD
+0.04 (+7.29%)
0.5832 USD
-0.05 (-7.25%)
SESN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for SESN as it has an excellent financial health rating, but there are worries on the profitability. SESN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year SESN has reported negative net income.
- SESN had a positive operating cash flow in the past year.
1.2 Ratios
- The profitability ratios for SESN are negative, so there is not much use analyzing them.
- SESN has a better Return On Invested Capital (14.26%) than 97.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 14.26% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Operating Margin, with a value of 49.65%, SESN belongs to the top of the industry, outperforming 98.90% of the companies in the same industry.
- In the last couple of years the Operating Margin of SESN has grown nicely.
- The Profit Margin and Gross Margin are not available for SESN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 49.65% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5Y62.37%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SESN is creating some value.
- SESN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- SESN has an Altman-Z score of 1.65. This is a bad value and indicates that SESN is not financially healthy and even has some risk of bankruptcy.
- SESN's Altman-Z score of 1.65 is fine compared to the rest of the industry. SESN outperforms 66.67% of its industry peers.
- There is no outstanding debt for SESN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 1.65 |
ROIC/WACC1.61
WACC8.88%
2.3 Liquidity
- SESN has a Current Ratio of 5.54. This indicates that SESN is financially healthy and has no problem in meeting its short term obligations.
- SESN's Current ratio of 5.54 is in line compared to the rest of the industry. SESN outperforms 49.06% of its industry peers.
- A Quick Ratio of 5.54 indicates that SESN has no problem at all paying its short term obligations.
- The Quick ratio of SESN (5.54) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.54 | ||
| Quick Ratio | 5.54 |
3. Growth
3.1 Past
- The earnings per share for SESN have decreased strongly by -364.00% in the last year.
- The Revenue has grown by 816.87% in the past year. This is a very strong growth!
- Measured over the past years, SESN shows a decrease in Revenue. The Revenue has been decreasing by -2.41% on average per year.
EPS 1Y (TTM)-364%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%455.56%
Revenue 1Y (TTM)816.87%
Revenue growth 3YN/A
Revenue growth 5Y-2.41%
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 12.42% on average over the next years. This is quite good.
- Based on estimates for the next years, SESN will show a very negative growth in Revenue. The Revenue will decrease by -14.87% on average per year.
EPS Next Y-308%
EPS Next 2Y4.02%
EPS Next 3Y19.21%
EPS Next 5Y12.42%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for SESN. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SESN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- SESN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SESN is cheaper than 97.96% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.31 | ||
| EV/EBITDA | -5.23 |
4.3 Compensation for Growth
- SESN's earnings are expected to grow with 19.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.02%
EPS Next 3Y19.21%
5. Dividend
5.1 Amount
- SESN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SESEN BIO INC / SESN FAQ
Can you provide the ChartMill fundamental rating for SESEN BIO INC?
ChartMill assigns a fundamental rating of 3 / 10 to SESN.
What is the valuation status for SESN stock?
ChartMill assigns a valuation rating of 2 / 10 to SESEN BIO INC (SESN). This can be considered as Overvalued.
How profitable is SESEN BIO INC (SESN) stock?
SESEN BIO INC (SESN) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for SESN stock?
The Earnings per Share (EPS) of SESEN BIO INC (SESN) is expected to decline by -308% in the next year.